-
February 26, 2010
New drug will offer a treatment alternative for patients with rare genetic disorder
The U.S. Food and Drug Administration has approved...
-
February 26, 2010
Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the...
-
February 24, 2010
Partnership Combines Strengths to Speed New Treatments to Patients
The U.S. Food and Drug Administration and the National Institutes of Health...
-
February 23, 2010
Review of data indicating life-threatening heart abnormality underway
The U.S. Food and Drug Administration today announced preliminary data suggesting that Invirase...
-
February 19, 2010
Data focus on genetic basis of drug-induced liver injury and serious skin reaction -
The U.S. Food and Drug Administration and...
-
February 18, 2010
The U.S. Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never...
-
February 18, 2010
Agency Analysis: More than 50 new cancer indications approved over a 32–month period
The U.S. Food and Drug Administration’s Office of...
-
February 18, 2010
The U.S. Food and Drug Administration today approved Rituxan (rituximab) to treat certain patients with chronic lymphocytic leukemia (CLL), a...
-
February 16, 2010
The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about...
-
February 12, 2010
The European Commission granted approval of a new tablet formulation of Abbott’s antiretroviral medication Norvir® (ritonavir) on Jan. 25, 2010....
